The largest database of trusted experimental protocols

Anti cd68 pe cy7

Manufactured by Thermo Fisher Scientific
Sourced in United States

Anti-CD68-PE-Cy7 is a fluorescently-labeled antibody used for flow cytometry analysis. It binds to the CD68 surface antigen, which is expressed on monocytes, macrophages, and other myeloid cells. The PE-Cy7 fluorophore allows for detection and quantification of CD68-positive cells.

Automatically generated - may contain errors

2 protocols using anti cd68 pe cy7

1

Multicolor Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used were: anti-TCRβ-APC-Cy7 (BD Pharmigen, clone H57–597), anti-CD44-BV605 (BD Horizon, clone IM7), anti-CD4-PE-Cy7 (BD Pharmigen, clone RM4–5), anti-CD8α-PE (BD Pharmigen, clone H35–17.2), anti-CD8β-PerCP-Cy5.5 (BioLegend, clone YTS156.7.7), anti-T1/ST2-biotin (MD Bioproducts, clone DJ8), Streptavidin-PE (ebioscience), anti-Foxp3-FITC (eBioscience, clone FJK-16s), anti-Tbet-ef660 (eBioscience, clone eBio4B10), anti-Ki67-AF700 (BD Pharmigen, clone B56), anti-Ly6C-PerCp-Cy5.5 (eBioscience, clone HK1.4), anti-CD11b-BV605 (BD Horizon, clone M1/70), anti-Ly6G-PECF94 (BD Horizon, clone 1A8), anti-ICOS-PE-Cy5 (eBiosicence, clone 7E.17G9), anti-CD25-PerCP-Cy5.5 (BD Pharmigen, clone, PC61), anti-IFNγ-BV650 (BD Horizon, clone XMG1.2), anti-CD45-V450 (BD Horizon, clone 30-F11), anti-Nos2-AF488 (eBioscience, clone CXNFT), anti-CD68-PE-Cy7 (eBioscience, clone FA-11), and anti-CD206-APC (BioLegend, clone C068C2). Flow cytometry data was acquired using a BD LSRFortessa Cell Analyzer and analyzed using FlowJo version 10.4.2 (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of TLR2 and TLR4 Expression in PBEC and MQ

Check if the same lab product or an alternative is used in the 5 most similar protocols
To distinguish between PBEC and MQ in PBEC-ALI/MQ, cells were trypsinized and washed twice with PBS, and incubated with monoclonal antibody (anti-CD68-PE-Cy7; Cat No.25-0689-42, eBioscience, Thermo Fisher Scientific, Pittsburgh, United States). The CD68 + cells were MQ and CD68 cells were PBEC. To analyze the expression of TLR2 and TLR4, the trypsinized cells were incubated with monoclonal antibodies (anti-TLR2-APC, Cat No.558319, BD Pharmingen, San Diego, CA, United States; anti-TLR4-PE, Cat No.12-9917-42, eBioscience, Thermo Fisher Scientific, Pittsburgh, United States) for 30 mins in dark. The cells were then washed 3 times and re-suspended in PBS. For PBEC-ALI, the TLR2/TLR4 were detected directly. For PBEC-ALI/MQ, the cells were gated by anti-CD68 antibody first followed by TLR2/TLR4 detection in both CD68 + cell populations (MQ) and CD68 cell populations (PBEC). For all analysis, unstained cells were used to provide the gating controls for determining positivity [46 (link)]. Analyses were performed using the flow cytometer (LSR Fortessa™, BD Bioscienc, United States) and calculated as median fluorescence intensity (MFI).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!